Rextor Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit 40.48%
(FY 2020)
- Ebitda 40.48%
(FY 2020)
- Net Worth
- Total Assets -23.01%
(FY 2020)
About Rextor Pharmaceuticals
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohidas Ambhore and Narayan Bainade serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC285997
- Company No.
285997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rextor Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohidas Ambhore  | Director | 19-Sep-2016 | Current |
| Narayan Bainade | Director | 19-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Rextor Pharmaceuticals.
Rextor Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.48% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rextor Pharmaceuticals?
Unlock access to Rextor Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Yaagrogreen Farmer Producer Company Limited
Active 2 years 2 monthsRohidas Ambhore is a mutual person
Naturespride Farmer Producer Company Limited
Active 2 years 2 monthsRohidas Ambhore is a mutual person
Krushishashwati Farmer Producer Company Limited
Active 2 years 1 monthRohidas Ambhore is a mutual person
Krushibhaskar Farmer Producer Company Limited
Active 2 years 1 monthRohidas Ambhore is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rextor Pharmaceuticals?
Unlock and access historical data on people associated with Rextor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rextor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rextor Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
